143 related articles for article (PubMed ID: 30389435)
1. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
Petcherski A; Trudeau KM; Wolf DM; Segawa M; Lee J; Taddeo EP; Deeney JT; Liesa M
J Mol Biol; 2018 Dec; 430(24):4823-4833. PubMed ID: 30389435
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial Protection Partly Mitigates Kidney Cellular Senescence in Swine Atherosclerotic Renal Artery Stenosis.
Kim SR; Eirin A; Zhang X; Lerman A; Lerman LO
Cell Physiol Biochem; 2019; 52(3):617-632. PubMed ID: 30907989
[TBL] [Abstract][Full Text] [Related]
3. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Zhao W; Xu Z; Cao J; Fu Q; Wu Y; Zhang X; Long Y; Zhang X; Yang Y; Li Y; Mi W
J Neuroinflammation; 2019 Nov; 16(1):230. PubMed ID: 31747905
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle-mediated lysosomal reacidification restores mitochondrial turnover and function in β cells under lipotoxicity.
Assali EA; Shlomo D; Zeng J; Taddeo EP; Trudeau KM; Erion KA; Colby AH; Grinstaff MW; Liesa M; Las G; Shirihai OS
FASEB J; 2019 Mar; 33(3):4154-4165. PubMed ID: 30550357
[TBL] [Abstract][Full Text] [Related]
5. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
6. Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad A; Herrmann SMS; Eirin A; Ferguson CM; Glockner JF; Bjarnason H; McKusick MA; Misra S; Lerman LO; Textor SC
Circ Cardiovasc Interv; 2017 Sep; 10(9):. PubMed ID: 28916603
[TBL] [Abstract][Full Text] [Related]
7. The rescue of microtubule-dependent traffic recovers mitochondrial function in Parkinson's disease.
Esteves AR; Gozes I; Cardoso SM
Biochim Biophys Acta; 2014 Jan; 1842(1):7-21. PubMed ID: 24120997
[TBL] [Abstract][Full Text] [Related]
8. The effects of a mitochondrial targeted peptide (elamipretide/SS31) on BAX recruitment and activation during apoptosis.
Grosser JA; Fehrman RL; Keefe D; Redmon M; Nickells RW
BMC Res Notes; 2021 May; 14(1):198. PubMed ID: 34022923
[TBL] [Abstract][Full Text] [Related]
9. Imaging the Dynamics of Mitophagy in Live Cells.
Moore AS; Holzbaur ELF
Methods Mol Biol; 2019; 1880():601-610. PubMed ID: 30610725
[TBL] [Abstract][Full Text] [Related]
10. Fatty acids suppress autophagic turnover in β-cells.
Las G; Serada SB; Wikstrom JD; Twig G; Shirihai OS
J Biol Chem; 2011 Dec; 286(49):42534-42544. PubMed ID: 21859708
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial breakdown in skeletal muscle and the emerging role of the lysosomes.
Triolo M; Hood DA
Arch Biochem Biophys; 2019 Jan; 661():66-73. PubMed ID: 30439362
[TBL] [Abstract][Full Text] [Related]
12. A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.
Reid Thompson W; Hornby B; Manuel R; Bradley E; Laux J; Carr J; Vernon HJ
Genet Med; 2021 Mar; 23(3):471-478. PubMed ID: 33077895
[TBL] [Abstract][Full Text] [Related]
13. The cardiolipin-binding peptide elamipretide mitigates fragmentation of cristae networks following cardiac ischemia reperfusion in rats.
Allen ME; Pennington ER; Perry JB; Dadoo S; Makrecka-Kuka M; Dambrova M; Moukdar F; Patel HD; Han X; Kidd GK; Benson EK; Raisch TB; Poelzing S; Brown DA; Shaikh SR
Commun Biol; 2020 Jul; 3(1):389. PubMed ID: 32680996
[TBL] [Abstract][Full Text] [Related]
14. Nε-(carboxymethyl) lysine-induced mitochondrial fission and mitophagy cause decreased insulin secretion from β-cells.
Lo MC; Chen MH; Lee WS; Lu CI; Chang CR; Kao SH; Lee HM
Am J Physiol Endocrinol Metab; 2015 Nov; 309(10):E829-39. PubMed ID: 26394662
[TBL] [Abstract][Full Text] [Related]
15. Drp1 guarding of the mitochondrial network is important for glucose-stimulated insulin secretion in pancreatic beta cells.
Reinhardt F; Schultz J; Waterstradt R; Baltrusch S
Biochem Biophys Res Commun; 2016 Jun; 474(4):646-651. PubMed ID: 27154223
[TBL] [Abstract][Full Text] [Related]
16. Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.
Sabbah HN
Heart Fail Rev; 2022 Sep; 27(5):1911-1923. PubMed ID: 34623544
[TBL] [Abstract][Full Text] [Related]
17. Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins.
Whitson JA; Martín-Pérez M; Zhang T; Gaffrey MJ; Merrihew GE; Huang E; White CC; Kavanagh TJ; Qian WJ; Campbell MD; MacCoss MJ; Marcinek DJ; Villén J; Rabinovitch PS
Geroscience; 2021 Oct; 43(5):2395-2412. PubMed ID: 34480713
[TBL] [Abstract][Full Text] [Related]
18. TRPM2-mediated rise in mitochondrial Zn
Li F; Munsey TS; Sivaprasadarao A
Cell Death Differ; 2017 Dec; 24(12):1999-2012. PubMed ID: 28753206
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of a Small Mitochondrially-Targeted Tetrapeptide Elamipretide in Neurodegeneration.
Nhu NT; Xiao SY; Liu Y; Kumar VB; Cui ZY; Lee SD
Front Integr Neurosci; 2021; 15():747901. PubMed ID: 35111001
[TBL] [Abstract][Full Text] [Related]
20. Targeting mitochondrial dysfunction with elamipretide.
Obi C; Smith AT; Hughes GJ; Adeboye AA
Heart Fail Rev; 2022 Sep; 27(5):1925-1932. PubMed ID: 35037146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
